Tech Company Financing Transactions

Cardiosense Funding Round

On 12/9/2022, Cardiosense secured $15.1 million in Series A investment from Broadview Ventures, Hatteras Venture Partners and Laerdal Million Lives Fund.

Transaction Overview

Company Name
Announced On
12/9/2022
Transaction Type
Venture Equity
Amount
$15,100,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to support team expansion, accelerate product development, and fund an expansive heart failure study.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
400 N Aberdeen St 900
Chicago, IL 60642
USA
Phone
Undisclosed
Email Address
Overview
Cardiosense is building a digital biomarker platform that leverages novel, multi-sensor devices and proprietary algorithms to detect early signs of disease and guide personalized therapy
Profile
Cardiosense LinkedIn Company Profile
Social Media
Cardiosense Company Twitter Account
Company News
Cardiosense News
Facebook
Cardiosense on Facebook
YouTube
Cardiosense on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amit Gupta
  Amit  Gupta LinkedIn Profile  Amit  Gupta Twitter Account  Amit  Gupta News  Amit  Gupta on Facebook
Chief Technical Officer
Andrew Carek
  Andrew Carek LinkedIn Profile  Andrew Carek Twitter Account  Andrew Carek News  Andrew Carek on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/9/2022: Field Effect venture capital transaction
Next: 12/9/2022: Interpres Security venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary